CAFTA-DR – Origin Cumulation Pharmaceutical Products

Quelle: https://www.trade.gov/cafta-dr

CAFTA-DR – Origin cumulation refers to the mechanism under the Central America Free Trade Agreement – Dominican Republic that allows countries to apply common origin rules for pharmaceutical products in order to obtain tariff benefits.

Related Terms

You might also be interested in these terms

CAFTA‑DR

The Central American Free Trade Agreement - Dominican Republic (CAFTA-DR) is a trade agreement between the United States and Costa Rica, El Salvador, ...

Learn more

CAFTA-DR – Origin Cumulation Shoes

Origin cumulation under CAFTA-DR allows shoes produced in the signatory countries to be recognized as originating products, even if components come fr...

Learn more

CPTPP – Origin Accumulation Pharmaceutical Products

The CPTPP origin accumulation refers to a regulation under the Comprehensive and Progressive Agreement for Trans-Pacific Partnership that allows pharm...

Learn more

EFTA–Chile FTA – Origin Cumulation Pharmaceutical Products

The EFTA-Chile Free Trade Agreement allows for origin cumulation for pharmaceutical products, meaning that these products can benefit from the accumul...

Learn more

EFTA–China FTA – Origin Cumulation Pharmaceutical Products

Origin cumulation under the EFTA–China FTA refers to the regulation that allows materials and products from certain EFTA states and China to be aggreg...

Learn more

CAFTA-DR – Origin Cumulation Plastics

CAFTA-DR refers to the trade agreement between the USA, Central American countries, and the Dominican Republic that allows for origin cumulation for p...

Learn more